Jean C. Emond, Peter F. Whitington, J. Richard Thistlethwaite, Estella M. Alonso, Christoph E. Broelsch – 1 November 1989 – Reducing the size of a liver for use in a recipient smaller than the donor is one way to reduce mortality before orthotopic liver transplantation in children because of the scarcity of pediatric organ donors. In this report, we review the results of this approach over the past 2 years, during which we have used reduced‐size orthotopic liver transplantation routinely in small children.

Denis J. Morgan, Richard A. Smallwood – 1 November 1989 – Blood clearance of antipyrine, indocyanine green, and galactose were measured to evaluate the alterations of effective hepatic blood flow and hepatic intrinsic clearances in chronic liver diseases. Galactose blood clearance, which may be taken as effective hepatic blood flow, decreased by approximately 30% in patients with cirrhosis (12.49 ± 0.76 ml/min/kg; mean ± SE; n = 17) compared with normal subjects (18.17 ± 1.03 ml/min/kg; n = 5).

Samuel W. French, H. Tsukamoto, Esteban Mezey – 1 November 1989

Neil A. Kurtzman – 1 November 1989

Yves Ozier, Alain Braillon, Christophe Gaudin, Dominique Roulot, Antoine Hadengue, Didier Lebrec – 1 October 1989 – We investigated the effect of liver denervation on cardiovascular homeostasis. Three days after surgical denervation of the liver, hemodynamic studies (radioactive microsphere method) were conducted in conscious rats. The efficacity of the liver denervation procedure was confirmed by a significant decrease in norepinephrine content in various lobes of the liver. Liver denervation did not affect either systemic or splanchnic resting hemodynamics.

Dieter Jüngst – 1 October 1989 – Gallbladder biles and stones were obtained at 116 cholecystectomies for symptomatic gallstone disease. All 33 patients younger than 50 years had cholesterol stones, whereas 40% of the older patients had pigment stones. We compared the reliability of three different bile tests for the differentiation between cholesterol and pigment stone patients.

Dominique Valla, Jean‐François Flejou, Didier Lebrec, Jacques Bernuau, Bernard Rueff, Jean‐Louis Salzmann, Jean‐Pierre Benhamou – 1 October 1989 – We attempted to ascertain the mechanism of portal hypertension and ascites complicating acute hepatitis in 66 patients who underwent transvenous liver biopsy and measurement of hepatic venous pressure gradient.

1 October 1989

Helmut Denk, Kurt Zatloukal, Karl‐Heinz Preisegger – 1 October 1989 – Polyclonal antibodies were raised which have a high affinity for conjugated ubiquitin. Immuno‐cytochemistry was performed on paraffin sections of tissues showing well‐characterized inclusion bodies. Ubiquitin was found as a component of the intermediate filament inclusion bodies characteristic of several major diseases including Lewy bodies of Parkinson's disease, Pick bodies of Pick's disease, Mallory bodies of alcoholic liver disease, cytoplasmic bodies of a specific myopathy, and Rosenthal fibres within astrocytes.

Russell H. Wiesner, Patricia M. Grambsch, E. Rolland Dickson, Jurgen Ludwig, Robert L. Maccarty, Ellen B. Hunter, Thomas R. Fleming, Lloyd D. Fisher, Sandra J. Beaver, Nicholas F. Larusso – 1 October 1989 – The natural history of primary sclerosing cholangitis was assessed in 174 patients; 37 were asymptomatic and 137 had symptoms related to underlying liver disease. At the time of diagnosis, the mean age was 39.9 years, 66% of the primary sclerosing cholangitis patients were male and 71% had associated inflammatory bowel disease, most commonly chronic ulcerative colitis.